Insider Buy/Sell Details for the Biotechnology Industry — April 2026
Ratio0.0:1
Daily Buy & Sell Volume
Transactions (157)
Immunome Inc. (IMNM)
Rosett Max — Chief Financial Officer
Shares
1,344
Price
$22.48
Total Value
$30.21K
Shares Held After
54,037
% of Holdings
2.4%
Immunome Inc. (IMNM)
Rosett Max — Chief Financial Officer
Shares
63,656
Price
$21.91
Total Value
$1.39M
Shares Held After
55,381
% of Holdings
53.5%
Immunome Inc. (IMNM)
Higgins Jack — Chief Scientific Officer
Shares
9,438
Price
$21.64
Total Value
$204.24K
Shares Held After
22,000
% of Holdings
30.0%
Whitehawk Therapeutics, Inc. (WHWK)
Lennon David James — Director
Shares
26,858
Price
$3.48
Total Value
$93.47K
Shares Held After
793,549
% of Holdings
3.3%
Zai Lab Ltd (ZLAB)
Du Ying — Director
Shares
5,576
Price
$20.39
Total Value
$113.69K
Shares Held After
1,125,279
% of Holdings
0.5%
Zai Lab Ltd (ZLAB)
Chen Yajing — Chief Financial Officer
Shares
5,199
Price
$20.39
Total Value
$106.01K
Shares Held After
32,558
% of Holdings
13.8%
Zai Lab Ltd (ZLAB)
Smiley Joshua L — President and Chief Operating Officer
Shares
9,614
Price
$20.39
Total Value
$196.03K
Shares Held After
120,619
% of Holdings
7.4%
Zai Lab Ltd (ZLAB)
Amado Rafael — President, Head of Global Oncology Research and Development
Shares
9,910
Price
$20.39
Total Value
$202.06K
Shares Held After
59,761
% of Holdings
14.2%
Voyager Therapeutics, Inc. (VYGR)
Sandrock Alfred — Director
Shares
11,511
Price
$3.87
Total Value
$44.55K
Shares Held After
472,549
% of Holdings
2.4%
Zai Lab Ltd (ZLAB)
Edmondson Frazor Titus III — Chief Legal Officer
Shares
4,194
Price
$20.39
Total Value
$85.52K
Shares Held After
24,590
% of Holdings
14.6%
CAPRICOR THERAPEUTICS, INC. (CAPR)
Sabar Karimah Es — Director
Shares
7,529
Price
$32.00
Total Value
$240.93K
Shares Held After
0
% of Holdings
100.0%
Annovis Bio, Inc. (ANVS)
Hoffman Michael B — Director
Shares
713,800
Price
$2.10
Total Value
$1.50M
Shares Held After
3,288,539
% of Holdings
21.7%
Immunovant, Inc. (IMVT)
Venker Eric — Director
Shares
1,409
Price
$24.60
Total Value
$34.66K
Shares Held After
19,561
% of Holdings
6.7%
Immunovant, Inc. (IMVT)
Venker Eric — Director
Shares
12,820
Price
$24.04
Total Value
$308.19K
Shares Held After
20,970
% of Holdings
37.9%
Avalo Therapeutics, Inc. (AVTX)
Sullivan Christopher Ryan — Chief Financial Officer
Shares
1,780
Price
$17.57
Total Value
$31.27K
Shares Held After
17,338
% of Holdings
9.3%
Avalo Therapeutics, Inc. (AVTX)
Sullivan Christopher Ryan — Chief Financial Officer
Shares
6,200
Price
$17.02
Total Value
$105.55K
Shares Held After
19,118
% of Holdings
24.5%
ADC Therapeutics SA (ADCT)
Redmile Group, LLC — 10% Owner
Shares
2,529,491
Price
$3.28
Total Value
$8.29M
Shares Held After
10,265,297
% of Holdings
19.8%
ADC Therapeutics SA (ADCT)
Redmile Group, LLC — 10% Owner
Shares
2,634,506
Price
$3.28
Total Value
$8.64M
Shares Held After
12,666,731
% of Holdings
17.2%
Kodiak Sciences Inc. (KOD)
BORGESON JOHN A. — Chief Financial Officer
Shares
600
Price
$41.77
Total Value
$25.06K
Shares Held After
183,316
% of Holdings
0.3%
Kodiak Sciences Inc. (KOD)
BORGESON JOHN A. — Chief Financial Officer
Shares
4,231
Price
$40.88
Total Value
$172.96K
Shares Held After
183,916
% of Holdings
2.2%
Kodiak Sciences Inc. (KOD)
BORGESON JOHN A. — Chief Financial Officer
Shares
12,477
Price
$40.29
Total Value
$502.70K
Shares Held After
188,147
% of Holdings
6.2%
Kodiak Sciences Inc. (KOD)
BORGESON JOHN A. — Chief Financial Officer
Shares
12,692
Price
$39.14
Total Value
$496.76K
Shares Held After
200,624
% of Holdings
5.9%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
200
Price
$571.61
Total Value
$114.32K
Shares Held After
45,172
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
710
Price
$569.61
Total Value
$404.42K
Shares Held After
45,372
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
690
Price
$568.79
Total Value
$392.47K
Shares Held After
46,082
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,403
Price
$567.55
Total Value
$796.27K
Shares Held After
46,772
% of Holdings
2.9%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,629
Price
$566.66
Total Value
$923.10K
Shares Held After
48,175
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
543
Price
$565.66
Total Value
$307.15K
Shares Held After
49,804
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,115
Price
$564.55
Total Value
$629.48K
Shares Held After
50,347
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
371
Price
$563.58
Total Value
$209.09K
Shares Held After
51,462
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
774
Price
$562.34
Total Value
$435.25K
Shares Held After
51,833
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
351
Price
$561.69
Total Value
$197.15K
Shares Held After
52,607
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
514
Price
$560.30
Total Value
$287.99K
Shares Held After
52,958
% of Holdings
1.0%
IONIS PHARMACEUTICALS INC (IONS)
Devers Shannon L. — EVP, Chief Human Resources Ofc
Shares
6,193
Price
$74.05
Total Value
$458.61K
Shares Held After
16,348
% of Holdings
27.5%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$14.60
Total Value
$278.28K
Shares Held After
447,202
% of Holdings
4.1%
Nurix Therapeutics, Inc. (NRIX)
Ring Christine — Chief Legal Officer
Shares
8,148
Price
$15.24
Total Value
$124.15K
Shares Held After
26,453
% of Holdings
23.5%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
4,200
Price
$64.89
Total Value
$272.53K
Shares Held After
767,780
% of Holdings
0.5%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
15,800
Price
$64.06
Total Value
$1.01M
Shares Held After
771,980
% of Holdings
2.0%
Lipocine Inc. (LPCN)
Patel Mahesh V. — Director
Shares
25,000
Price
$2.02
Total Value
$50.50K
Shares Held After
135,679
% of Holdings
18.4%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
1,300
Price
$49.98
Total Value
$64.97K
Shares Held After
97,994
% of Holdings
1.3%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
6,200
Price
$49.21
Total Value
$305.10K
Shares Held After
99,294
% of Holdings
5.9%
Spyre Therapeutics, Inc. (SYRE)
Sloan Sheldon — Chief Medical Officer
Shares
7,958
Price
$50.00
Total Value
$397.90K
Shares Held After
0
% of Holdings
100.0%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
2,656
Price
$49.92
Total Value
$132.59K
Shares Held After
627,540
% of Holdings
0.4%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
12,344
Price
$49.20
Total Value
$607.32K
Shares Held After
630,196
% of Holdings
1.9%
Apogee Therapeutics, Inc. (APGE)
Dambkowski Carl — Chief Medical Officer
Shares
100
Price
$85.89
Total Value
$8.59K
Shares Held After
208,398
% of Holdings
0.0%
Apogee Therapeutics, Inc. (APGE)
Dambkowski Carl — Chief Medical Officer
Shares
2,702
Price
$85.33
Total Value
$230.56K
Shares Held After
208,498
% of Holdings
1.3%
Apogee Therapeutics, Inc. (APGE)
Dambkowski Carl — Chief Medical Officer
Shares
2,698
Price
$84.31
Total Value
$227.47K
Shares Held After
211,200
% of Holdings
1.3%
Apogee Therapeutics, Inc. (APGE)
Henderson Jane — Chief Financial Officer
Shares
1,100
Price
$85.46
Total Value
$94.01K
Shares Held After
177,371
% of Holdings
0.6%
Apogee Therapeutics, Inc. (APGE)
Henderson Jane — Chief Financial Officer
Shares
900
Price
$84.46
Total Value
$76.01K
Shares Held After
178,471
% of Holdings
0.5%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
40
Price
$779.71
Total Value
$31.19K
Shares Held After
17,603
% of Holdings
0.2%
Showing 1–50 of 157 transactions (page 1 of 4)